Zoetis’ Lenivia® (izenivetmab) receives Health Canada approval and a positive opinion from the European Medicines Agency, paving the way for the world’s first three-month monoclonal antibody therapy for canine osteoarthritis pain.
The FDA has granted an Emergency Use Authorization for Elanco’s Credelio™ (lotilaner) to treat New World screwworm infestations in dogs—marking the first authorization of its kind as the parasite nears the U.S. border.
Phibro Animal Health has launched Restoris™, a new piezoelectric dental gel for dogs designed to promote bone growth and restore oral health in cases of periodontal disease.
Akston has initiated a Purdue University clinical trial of its Ambifect® immuno-enhancing protein therapy targeting PD-L1 in dogs with solid tumors — marking the company’s first in-clinic study of its novel Fc-fusion platform.
Sign up for free to receive the latest veterinary news, product announcements, and industry developments.